These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18686632)

  • 1. Effects of glucagon on islet beta cell function in patients with diabetes mellitus.
    Wang T; Xiao XH; Li WH; Wang H; Sun Q; Yuan T; Yang GH
    Chin Med Sci J; 2008 Jun; 23(2):117-20. PubMed ID: 18686632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    Eur J Pediatr; 2008 Jul; 167(7):801-5. PubMed ID: 17874132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
    Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
    Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effect of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Iversen S; Faber OK; Frøland A
    Scand J Clin Lab Invest; 1989 Jun; 49(4):337-43. PubMed ID: 2662383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.
    Madsbad S; Krarup T; McNair P; Christiansen C; Faber OK; Transbøl I; Binder C
    Acta Med Scand; 1981; 210(3):153-6. PubMed ID: 7027749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.
    Matsuda A; Kamata I; Iwamoto Y; Sakamoto Y; Kuzuya T
    Diabetes Res Clin Pract; 1985 Oct; 1(3):161-7. PubMed ID: 3915262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
    Schnell O; Eisfelder B; Standl E; Ziegler AG
    Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
    Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group.
    Skyler JS; Rabinovitch A
    J Diabetes Complications; 1992; 6(2):77-88. PubMed ID: 1611143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
    van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW
    Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.
    Björk E; Berne C; Karlsson FA
    Diabetes Care; 1998 Mar; 21(3):427-30. PubMed ID: 9540027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.